COVID-19 vaccine data
This page is updated weekly at 1pm on Wednesday. Vaccine data is up to Sunday 22 March 2026.
On this page
- About COVID-19 vaccine data
- COVID-19 vaccinations summary
- Total vaccinations
- Booster breakdowns
- Vaccine uptake percentage by age band
- Vaccine uptake percentage by age band image blo
- Vaccine uptake percentage by district of residence 12 years and older
- Vaccine uptake percentage by district of residence 12 years and older image block
- Vaccinations by week
- Vaccinations by week image image block
- Adverse events following immunisations (AEFI)
About COVID-19 vaccine data
All data comes from the Aotearoa Immunisation Register (AIR).
- Metrics on this page can use 1 of 2 views of the data.
- Operational view — shows all doses administered in New Zealand.
Person view — shows the vaccination status of people regardless of how that was recorded or whether it was in New Zealand.
Those who have been vaccinated overseas will only appear in the person view. The person view includes all people that are currently alive and in AIR.
On 12 June 2024, the estimated population was changed to be sourced from AIR instead of the most recent Health Service User (HSU).
COVID-19 vaccinations summary
| Metric | Total |
| Second boosters administered | 1,132,063 |
| Total doses administered | 14,136,529 |
| First boosters administered | 2,789,735 |
| Percentage of 12 years and older who have completed primary course | 82.2% |
| Percentage of eligible 50 years and older who have received second booster | 56.9% |
| Percentage of eligible 18 years and older who have received first booster | 70.6% |
Total vaccinations
This table is an operational view.
Definitions
- Cumulative total
- All vaccinations that have been administered and entered into the AIR and including Sunday 22 March 2026.
- Vaccinations last week
- Over the 7 days up to and including Sunday 22 March 2026.
| Dose | Vaccinations last week | Cumulative total |
| Primary course doses (12 and older) | 173 | 8,028,325 |
| Booster 1 | 206 | 2,789,735 |
| Booster 2 | 973 | 1,132,063 |
| Booster 3+ | 21,557 | 1,753,566 |
| Paediatric first dose | 17 | 273,162 |
| Paediatric second dose | 2 | 159,095 |
| Infant first dose | 0 | 245 |
| Infant second dose | 0 | 156 |
| Infant third dose | 0 | 182 |
| Total doses | 22,928 | 14,136,529 |
Booster breakdowns
These tables are a person view.
Booster counts by ethnicity
| Ethnicity | Booster 1 (16 to 17) | Booster 1 (18 and older) | Booster 2 (50 and older) |
| Māori | 168 | 260,372 | 70,311 |
| Pacific Peoples | 66 | 155,302 | 30,295 |
| Asian | 177 | 471,226 | 70,203 |
| Other | 964 | 1,795,801 | 705,403 |
| Total | 1,375 | 2,682,701 | 876,212 |
Booster 2 uptake by age group
| Age group | Eligible | Received | Uptake |
| 30 to 34 | 198,675 | 39,721 | 20.0% |
| 35 to 49 | 646,384 | 141,728 | 21.9% |
| 50 to 64 | 719,591 | 286,703 | 39.8% |
| 65 and older | 819,845 | 589,509 | 71.9% |
Vaccine uptake percentage by age band
Vaccine uptake percentage by district of residence 12 years and older
These figures do not include tamariki aged 0 to 11.
Vaccinations by week
Adverse events following immunisations (AEFI)
Like all medicines, the COVID-19 vaccine may cause side effects in some people. These side effects:
- are common
- are usually mild
- do not last long
- will not stop people from having the second dose or going about daily life.
Serious allergic reactions do happen but are extremely rare.
Suspected AEFI to COVID-19 vaccines are reported to the Centre for Adverse Reactions Monitoring (CARM). While Medsafe no longer publishes their COVID-19 vaccine safety reports, they continue to monitor reports of adverse reactions submitted to CARM.
Centre for Adverse Reactions Monitoring (CARM) — University of Otagoexternal link